GSKC títulos
Abaixo está a lista de títulos corporativos GSK PLC ADR Cert.Deposito Arg.Repr. 0.25 ADRs. Os investidores geralmente optam pelos títulos de uma empresa por sua maior estabilidade em épocas de volatilidade do mercado. Estude preços, rendimentos e outras estatísticas e encontre um investimento confiável.
Símbolo | YTM % | Volume | Preço % | Cupom % | Data de vencimento | Montante em circulação | Valor de face | Valor mín. de denominação | Emissor |
---|---|---|---|---|---|---|---|---|---|
GGSK6023695GlaxoSmithKline Capital, Inc. 4.5% 15-APR-2030 | — | 418 K | 101,74% | 4,50% | 2030-04-15 | 850 M USD | 1.000,00 USD | 2.000,00 USD | GlaxoSmithKline Capital, Inc. |
GGSK3981911GlaxoSmithKline Capital, Inc. 4.2% 18-MAR-2043 | — | 250 K | 88,04% | 4,20% | 2043-03-18 | 500 M USD | 1.000,00 USD | 2.000,00 USD | GlaxoSmithKline Capital, Inc. |
GGSK6023692GlaxoSmithKline Capital Plc FRN 12-MAR-2027 | — | 1,79 M | 100,24% | 4,86% | 2027-03-12 | 600 M USD | 1.000,00 USD | 2.000,00 USD | GlaxoSmithKline Capital Plc |
GGSK.GJGlaxoSmithKline Capital, Inc. 6.375% 15-MAY-2038 | — | 8 K | 113,59% | 6,38% | 2038-05-15 | 2,75 B USD | 1.000,00 USD | 2.000,00 USD | GlaxoSmithKline Capital, Inc. |
GGSK6023693GlaxoSmithKline Capital, Inc. 4.875% 15-APR-2035 | — | 6,41 M | 101,36% | 4,88% | 2035-04-15 | 750 M USD | 1.000,00 USD | 2.000,00 USD | GlaxoSmithKline Capital, Inc. |
GGSK6023691GlaxoSmithKline Capital Plc 4.315% 12-MAR-2027 | — | 40 K | 100,72% | 4,32% | 2027-03-12 | 400 M USD | 1.000,00 USD | 2.000,00 USD | GlaxoSmithKline Capital Plc |
UUS377373AH8GlaxoSmithKline Capital Plc 3.375% 01-JUN-2029 | — | 0 | 97,81% | 3,38% | 2029-06-01 | 1 B USD | 1.000,00 USD | 2.000,00 USD | GlaxoSmithKline Capital Plc |
XXS217060184GlaxoSmithKline Capital Plc 1.25% 12-OCT-2028 | — | 0 | 91,78% | 1,25% | 2028-10-12 | 750 M GBP | 1.000,00 GBP | 100.000,00 GBP | GlaxoSmithKline Capital Plc |
XXS168152035GlaxoSmithKline Capital Plc 1.375% 12-SEP-2029 | — | 0 | 95,24% | 1,38% | 2029-09-12 | 500 M EUR | 1.000,00 EUR | 100.000,00 EUR | GlaxoSmithKline Capital Plc |
UUS377372AN7GlaxoSmithKline Capital, Inc. 3.875% 15-MAY-2028 | — | 0 | 99,86% | 3,88% | 2028-05-15 | 1,75 B USD | 1.000,00 USD | 2.000,00 USD | GlaxoSmithKline Capital, Inc. |
XXS217060907GlaxoSmithKline Capital Plc 1.625% 12-MAY-2035 | — | 0 | 73,10% | 1,63% | 2035-05-12 | 750 M GBP | 1.000,00 GBP | 100.000,00 GBP | GlaxoSmithKline Capital Plc |
XXS255381768GSK Capital BV 3.0% 28-NOV-2027 | — | 0 | 101,21% | 3,00% | 2027-11-28 | 500 M EUR | 1.000,00 EUR | 100.000,00 EUR | GSK Capital BV |
XXS255381776GSK Capital BV 3.125% 28-NOV-2032 | — | 0 | 99,80% | 3,13% | 2032-11-28 | 700 M EUR | 1.000,00 EUR | 100.000,00 EUR | GSK Capital BV |
XXS182282979GlaxoSmithKline Capital Plc 1.75% 21-MAY-2030 | — | 0 | 95,29% | 1,75% | 2030-05-21 | 750 M EUR | 1.000,00 EUR | 100.000,00 EUR | GlaxoSmithKline Capital Plc |
GGX5BGlaxoSmithKline Capital Plc 1.0% 12-SEP-2026 | — | 0 | 98,81% | 1,00% | 2026-09-12 | 700 M EUR | 1.000,00 EUR | 100.000,00 EUR | GlaxoSmithKline Capital Plc |
XXS293369275GSK Capital BV 3.25% 19-NOV-2036 | — | 0 | 97,42% | 3,25% | 2036-11-19 | 600 M EUR | 1.000,00 EUR | 100.000,00 EUR | GSK Capital BV |
XXS293369143GSK Capital BV 2.875% 19-NOV-2031 | — | 0 | 99,16% | 2,88% | 2031-11-19 | 700 M EUR | 1.000,00 EUR | 100.000,00 EUR | GSK Capital BV |
XXS182282812GlaxoSmithKline Capital Plc 1.25% 21-MAY-2026 | — | 0 | 99,39% | 1,25% | 2026-05-21 | 1 B EUR | 1.000,00 EUR | 100.000,00 EUR | GlaxoSmithKline Capital Plc |
AAQ72GlaxoSmithKline Capital Plc 0.883% 21-SEP-2028 | — | — | — | 0,88% | 2028-09-21 | 42,5 B JPY | 100.000.000,00 JPY | 100.000.000,00 JPY | GlaxoSmithKline Capital Plc |
883GIGlaxoSmithKline Capital Plc 5.25% 10-APR-2042 | — | 0 | 94,53% | 5,25% | 2042-04-10 | 477,82 M GBP | 1.000,00 GBP | 50.000,00 GBP | GlaxoSmithKline Capital Plc |
117RIGlaxoSmithKline Capital Plc 4.25% 18-DEC-2045 | — | 8,46 K | 82,51% | 4,25% | 2045-12-18 | 370,79 M GBP | 1.000,00 GBP | 100.000,00 GBP | GlaxoSmithKline Capital Plc |
772WIGlaxoSmithKline Capital, Inc. 5.375% 15-APR-2034 | — | 0 | 105,28% | 5,38% | 2034-04-15 | 500 M USD | 1.000,00 USD | 1.000,00 USD | GlaxoSmithKline Capital, Inc. |
771ZCGlaxoSmithKline Capital Plc 6.375% 09-MAR-2039 | — | 0 | 107,50% | 6,38% | 2039-03-09 | 631,3 M GBP | 1.000,00 GBP | 50.000,00 GBP | GlaxoSmithKline Capital Plc |
117RNGlaxoSmithKline Capital Plc 3.375% 20-DEC-2027 | — | 0 | 112,19% | 3,38% | 2027-12-20 | 307,77 M GBP | 1.000,00 GBP | 100.000,00 GBP | GlaxoSmithKline Capital Plc |
AAG99GlaxoSmithKline Capital Plc 5.25% 19-DEC-2033 | — | 0 | 103,48% | 5,25% | 2033-12-19 | 574,17 M GBP | 1.000,00 GBP | 1.000,00 GBP | GlaxoSmithKline Capital Plc |